Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
AbstractFolate metabolism has been associated with cancers via alterations in nucleotide synthesis, DNA methylation, and DNA repair. We hypothesized that genetic variants in methylenetetrahydrofolate reductase (MTHFR), a key enzyme of folate metabolism, would affect the prognosis of prostate cancer. Three haplotype-tagging single-nucleotide polymorphisms (SNPs) across the MTHFR gene region were genotyped in a cohort of 458 patients with clinically localized prostate cancer treated with radical prostatectomy. One SNP, rs9651118, was associated with disease recurrence, and the association persisted after multivariate analyses adjusting for known risk factors. Public dataset analyses suggested that rs9651118 affects MTHFR expression. Quantitative real-time polymerase chain reaction analysis revealed that MTHFR expression is significantly upregulated in prostate tumor tissues when compared with adjacent normal tissues. Furthermore, overexpression of MTHFR correlates with cancer recurrence and death in two independent publicly available prostate cancer datasets. In conclusion, our data provide rationale to further validate the clinical utility of MTHFR rs9651118 as a biomarker for prognosis in prostate cancer. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 129 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Lin, V.C.; Lu, T.-L.; Yin, H.-L.; Yang, S.-F.; Lee, Y.-C.; Liu, C.-C.; Huang, C.-Y.; Yu, C.-C.; Chang, T.-Y.; Huang, S.-P.; Bao, B.-Y. Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer. Int. J. Mol. Sci. 2016, 17, 1996.
Lin VC, Lu T-L, Yin H-L, Yang S-F, Lee Y-C, Liu C-C, Huang C-Y, Yu C-C, Chang T-Y, Huang S-P, Bao B-Y. Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer. International Journal of Molecular Sciences. 2016; 17(12):1996.Chicago/Turabian Style
Lin, Victor C.; Lu, Te-Ling; Yin, Hsin-Ling; Yang, Sheau-Fang; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chao-Yuan; Yu, Chia-Cheng; Chang, Ta-Yuan; Huang, Shu-Pin; Bao, Bo-Ying. 2016. "Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer." Int. J. Mol. Sci. 17, no. 12: 1996.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.